Status:
COMPLETED
Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression
Lead Sponsor:
Zentrum für Integrative Psychiatrie
Collaborating Sponsors:
Stanley Medical Research Institute
Conditions:
Schizophrenia
Major Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
We investigate whether the add-on specific antitoxoplasmatic medication has positive effects in individuals with schizophrenia or major depression seropositive for Toxoplasma gondii (TG) infection. As...
Eligibility Criteria
Inclusion
- Schizophrenia or Major Depression
- Both genders
- Adult
- Patients are able to give informed consent
Exclusion
- Additional diagnosis of substance abuse/dependency
- Continuous treatment with medication not compatible with study medication
- Medical status not compatible with study medication
- Any condition that increases study risk considerably
- Pregnancy, nursing
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00300404
Start Date
January 1 2002
End Date
September 1 2005
Last Update
May 22 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.